Trial · NCT04803799
Registered outcomes20
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 20
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Postural control under dual-task condition change | Week 3, Week 17 | assessed by posturography (mm/s) |
| Secondary | Mental inhibition under dual-task condition change | Week 3, Week 17, Week 31 | assessed by Stroop test time (s) |
| Secondary | Mental inhibition under dual-task condition change | Week 3, Week 17, Week 31 | assessed by Stroop test errors (n) |
| Secondary | Mental inhibition change single-task condition | Week 3, Week 17, Week 31 | assessed by Stroop test time (s) |
| Secondary | Mental inhibition change single-task condition | Week 3, Week 17, Week 31 | assessed by Stroop test errors (n) |
| Secondary | Mental flexibility change | Week 3, Week 17, Week 31 | assessed by TMT time (s) |
| Secondary | Mental flexibility change | Week 3, Week 17, Week 31 | assessed by Stroop test errors (n) |
| Secondary | Working memory change | Week 3, Week 17, Week 31 | assessed by 2N-Back test errors (n) |
| Secondary | Mobility change | Week 3, Week 17, Week 31 | assessed by TUG time (s) |
| Secondary | Balance change | Week 3, Week 17, Week 31 | assessed by BBS score |
| Secondary | Fear of falling | Week 3, Week 17, Week 31 | assessed by FES-I score |
| Secondary | Postural control under single-task condition change | Week 3, Week 17, Week 31 | assessed by posturography (mm/s) |
| Secondary | Reported physical activity level change | Week 3, Week 17, Week 31 | assessed by QAPPA score |
| Secondary | Traqued physical activity level change | Week 3, Week 17, Week 31 | assessed by embeded Armband |
| Secondary | City exploration change | Week 17, Week 31 | assessed by the city's points of interest visits |
| Secondary | Quality of life change | Week 3, Week 17, Week 31 | assessed by EQ5D5L score |
| Secondary | Safety features of the training programme | Week 17 | number, nature, severity and causes of the occurrence of adverse events during the intervention |
| Secondary | Compliance | Week 17 | assessed by number of sessions carried out |
| Secondary | Drop-out | Week 17 | assessed by the number of participants who do not complete the program |
| Secondary | Motivation change | Week 3, Week 17, Week 31 | assessed by EMAPS score |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04803799/registered